STAA · Staar Surgical Co · Executive Compensation

$26.39 -0.39 (-1.46%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$1.32B

50.20M

Volume · Nov 13 370.21K Avg daily vol (3M) 875.85K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen C. Farrell	Chief Executive Officer	$580,000	—	$6,836,000	—	—	$106,385	$7,522,385
Warren Foust	President and Chief Operating Officer	$594,238	$250,000	$3,000,016	—	$567,000	$29,410	$4,440,664
Nathaniel B. Sisitsky	Chief Legal Officer and Corporate Secretary	$488,750	$75,000	$1,800,036	—	$381,150	$21,026	$2,765,962
Magda Michna	Chief Development Officer	$516,819	—	$1,800,036	—	$353,025	$25,872	$2,695,752
Deborah Andrews	Chief Financial Officer	$810,173	—	$1,400,016	—	$367,538	$4,684	$2,582,411
Thomas G. Frinzi	Former President and Chief Executive Officer	$167,154	—	—	—	—	$1,088,761	$1,255,915
Patrick F. Williams	Former Chief Financial Officer	$146,070	—	—	—	—	$780,871	$926,941

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas G. Frinzi	President and Chief Executive Officer	$820,000	—	$5,600,004	$1,399,993	—	$1,219	$7,821,216
Warren Foust	Chief Operating Officer	$570,731	—	$1,846,242	$461,558	—	$25,138	$2,903,669
Patrick F. Williams	Chief Financial Officer	$569,226	—	$1,841,349	$460,340	—	$27,974	$2,898,889
Magda Michna	Chief Clinical, Regulatory and Medical Affairs Officer	$492,904	$60,000	$1,395,164	$348,785	—	$16,830	$2,313,683
Nathaniel B. Sisitsky	General Counsel and Corporate Secretary	$470,000	—	$1,315,970	$328,991	—	$16,974	$2,131,935

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas G. Frinzi	President and Chief Executive Officer	$788,462	—	$4,499,989	$4,500,006	$430,500	$1,624	$10,220,581
Warren Foust	Chief Operating Officer	$359,615	—	$1,374,986	$1,374,997	$128,333	$12,361	$3,250,292
Patrick F. Williams	Chief Financial Officer	$541,385	—	$1,379,960	$689,991	$178,279	$27,254	$2,816,869
Scott Barnes	Chief Medical Officer	$535,971	—	$1,195,459	$597,708	$122,190	$32,988	$2,484,316
Keith Holliday	Chief Technology Officer	$517,564	—	$1,154,346	$577,176	$131,103	$30,628	$2,410,817

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Caren Mason	Former President and Chief Executive Officer	$852,318	$1,085,392	$3,032,242	$1,516,095	—	$15,906	$6,501,953
Patrick F. Williams	Chief Financial Officer	$513,462	—	$1,380,060	$690,010	$420,469	$26,054	$3,030,055
Scott Barnes	Chief Medical Officer	$508,327	—	$1,195,454	$597,699	$288,183	$31,788	$2,621,451
Keith Holliday	Chief Technology Officer	$490,869	—	$1,154,314	$577,202	$309,206	$29,014	$2,560,605
James Francese	Senior Vice President, Commercial Commercial Operations Asia Pacific and North America	$433,362	$296,875	$873,514	$911,764	—	$25,410	$2,540,925

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Caren Mason	Former President and Chief Executive Officer	$722,463	$1,230,646	$1,750,028	$1,749,994	—	$15,139	$5,468,270
Hans Blickensdoerfer	Senior Vice President, Commercial Operations Direct Markets Europe, China	$410,376	$346,206	—	$476,875	—	—	$3,550,231
Scott Barnes	Chief Medical Officer	$478,041	—	$265,356	$265,372	$365,351	$31,068	$1,405,188
Patrick F. Williams	Chief Financial Officer	$432,060	—	$227,125	$227,108	$477,569	$25,190	$1,389,052
Keith Holliday	Chief Technology Officer	$420,690	—	$223,329	$223,303	$373,990	$28,294	$1,269,606
James Francese	Senior Vice President, Commercial Commercial Operations Asia Pacific and North America	$370,051	$329,516	$196,034	$196,026	—	$24,690	$1,116,317

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hans Blickensdoerfer	Senior Vice President, Commercial Operations Direct Markets Europe, China	$411,643	$139,949	—	$423,440	—	—	$4,334,678
Caren Mason	Former President and Chief Executive Officer	$667,235	$380,287	—	$1,913,391	—	$14,899	$2,975,812
Patrick F. Williams	Chief Financial Officer	$182,308	$74,063	$1,579,982	—	—	$11,092	$1,847,445
Scott Barnes	Chief Medical Officer	$458,390	$138,448	$257,626	$257,634	—	$30,414	$1,142,512
Keith Holliday	Chief Technology Officer	$385,710	$131,058	$216,771	$216,785	—	$28,054	$978,378
James Francese	Senior Vice President, Commercial Commercial Operations Asia Pacific and North America	$338,639	$115,064	$190,315	$190,329	—	$24,450	$858,798

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Caren Mason	President and Chief Executive Officer	$626,895	$550,101	—	$2,423,766	—	$15,275	$3,616,037
Scott Barnes	Vice President, Chief Medical Officer	$445,039	$206,103	—	$565,033	—	$30,174	$1,246,350
Hans Blickensdoerfer	Senior Vice President, Commercial Operations Direct Markets Europe, China	$365,532	$195,659	—	$386,418	—	—	$1,076,798
Keith Holliday	Vice President, Chief Technology Officer	$374,476	$195,103	—	$475,433	—	$27,814	$1,072,826
Deborah Andrews	Vice President, Chief Financial Officer	$351,299	$167,112	—	$308,780	—	$27,021	$854,212

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Caren Mason	President and Chief Executive Officer	$585,312	$784,488	—	$1,241,915	—	$15,486	$2,627,201
Hans Blickensdoerfer	Senior Vice President, Commercial Operations Direct Markets Europe, China	$349,030	$277,362	—	$413,972	—	—	$1,102,581
Keith Holliday	Vice President, Chief Technology Officer	$363,569	$287,108	—	$413,972	—	$27,574	$1,092,223
Scott Barnes	Vice President, Chief Medical Officer	$435,001	$281,019	—	$206,986	—	$25,637	$948,643
Deborah Andrews	Vice President, Chief Financial Officer	$341,443	$251,797	—	$206,986	—	$23,254	$823,480

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Caren Mason	President and Chief Executive Officer	$562,800	$308,763	—	$980,300	—	$14,148	$1,866,011
Deborah Andrews	Vice President, Chief Financial Officer	$305,315	$96,778	$213,875	$226,073	—	$23,014	$865,056
Keith Holliday	Vice President, Chief Technology Officer	$352,214	$115,939	$174,375	$183,806	—	$26,974	$853,308
Hans Blickensdoerfer	Senior Vice President, Commercial Operations Direct Markets Europe, China	$339,327	$112,256	$104,625	$110,284	—	—	$699,424
Scott Barnes	Vice President, Chief Medical Officer	$100,385	$51,557	$190,625	$201,565	—	$64,194	$608,325

Executive changes

Person	Role	Change	Effective	Filed
David Bailey	Chief Commercial Officer	Appointed	2026-09-08	2026-09-10
Deborah Andrews	Executive Vice President (EVP)	Appointed	2026-08-04	2026-08-06
Warren Foust	member of the Board	Appointed	2026-08-04	2026-08-06
Warren Foust	President and Chief Executive Officer	Appointed	2026-08-04	2026-08-06
Nathaniel Sisitsky	Chief Legal Officer and Corporate Secretary	Terminated	2026-02-04	2026-02-05
Deborah Andrews	Interim Co-Chief Executive Officer	Appointed	2026-02-01	2026-02-02
Warren Foust	Interim Co-Chief Executive Officer	Appointed	2026-02-01	2026-02-02
Neal C. Bradsher	Board Chair	Appointed	2026-01-15	2026-01-16
Christopher Min Fang Wang	members of the Board	Appointed	2026-01-14	2026-01-15
Richard T. LeBuhn	members of the Board	Appointed	2026-01-14	2026-01-15
Neal C. Bradsher	members of the Board	Appointed	2026-01-14	2026-01-15
Elizabeth Yeu, MD	member of the Board	Resigned	2026-01-14	2026-01-15
Stephen C. Farrell	member of the Board	Resigned	2026-01-14	2026-01-15
Deborah Andrews	Chief Financial Officer	Appointed	2025-06-25	2025-06-25
Louis E. Silverman	director	Appointed	2025-04-24	2025-04-24
Patrick F. Williams	Chief Financial Officer	Resigned	2025-03-17	2025-03-18
Keith Holliday	Chief Technology Officer	Retired	2025-03-17	2025-03-18
Magda Michna	Chief Development Officer	Appointed	2025-03-17	2025-03-18
Deborah Andrews	principal accounting officer	Appointed	2025-03-17	2025-03-18
Deborah Andrews	Interim Chief Financial Officer	Appointed	2025-03-17	2025-03-18
Warren Foust	President and Chief Operating Officer	Appointed	2025-03-17	2025-03-18
Elizabeth Yeu	Board Chair	Appointed	2025-02-26	2025-02-26
Lilian Zhou	Chair of the Audit Committee	Appointed	2025-02-26	2025-02-26
Elizabeth Yeu, M.D.	Board Chair	Appointed	2025-02-26	2025-02-26
Stephen C. Farrell	President and Chief Executive Officer	Appointed	2025-02-26	2025-02-26

Leadership

Stephen C. Farrell CEO
Stephen Farrell CEO, Board Member
Thomas "Tom" G. Frinzi CEO
Thomas G. Frinzi CEO, Board Member
Elizabeth Yeu Chairman
Elizabeth Yeu, M.D. Chairman
Neal C. Bradsher Chairman, Board Member
Deborah Andrews CFO, Chief Accounting Officer
Patrick F. Williams CFO
Patrick Williams CFO
Warren Foust COO, Board Member
Arthur Butcher Board Member
Arthur C. Butcher Board Member
Christopher M. Wang Board Member
Christopher Min Fang Wang Board Member
Dr. Elizabeth Yeu Board Member
Dr. K. Peony Yu Board Member
Lilian Y. Zhou Board Member
Lilian Zhou Board Member
Lillian Zhou Board Member
Louis E. Silverman Board Member
Richard T. LeBuhn Board Member
Wei Jiang Board Member

Key facts CIK 718937 CUSIP 852312305 13F (30d) 164 filings 139 filers Visit website Investor relations